Related Experiment Video

Updated: Jul 16, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Para Vertebral Abscess and Rib Osteomyelitis due to Aspergillous Fumigatus in a Patient with Chronic Granulomatous

A Farhoudi1, A Siadati, Lila Atarod

  • 1Department of Immunology and Allergy, Department of Pediatric infectious disease, Children Medical Centre, Tehran University of Medical Sciences, Tehran, Iran.

Iranian Journal of Allergy, Asthma, and Immunology
|February 16, 2007
PubMed

Insights

Chronic granulomatous disease (CGD) patients face severe infections due to impaired microorganism killing. This case highlights invasive aspergillosis as a fatal complication, even with aggressive treatment.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Genetics

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency.
  • Patients experience recurrent, life-threatening bacterial and fungal infections due to defective intracellular killing.
  • Autosomal recessive CGD (AR-CGD) presents unique challenges in management.

Purpose of the Study:

  • To review the clinical course of a pediatric patient with AR-CGD.
  • To illustrate the severe manifestations and treatment complexities of CGD.
  • To emphasize the significant mortality associated with invasive fungal infections in CGD.

Main Methods:

  • Case report review of an 8-year-old girl with AR-CGD.
  • Documentation of clinical presentation, infections, and treatment interventions.
  • Analysis of treatment outcomes, including antifungal therapy, IFN-gamma, and surgical procedures.

Main Results:

  • The patient presented with recurrent abscesses, salmonellosis, BCGosis, and invasive aspergillosis affecting the mandible and pulmonary system.
  • Despite long-term intravenous amphotericin B, itraconazole, IFN-gamma, and surgical interventions, the patient's condition deteriorated.
  • Invasive aspergillosis, resistant to conventional therapies, was identified as the cause of death.

Conclusions:

  • Invasive aspergillosis remains a major cause of mortality in CGD patients.
  • Treatment resistance in invasive fungal infections poses a significant challenge in managing CGD.
  • Improved therapeutic strategies are crucial for improving outcomes in CGD, particularly for invasive fungal infections.

More Related Videos

Direct Observation of Phagocytosis and NET-formation by Neutrophils in Infected Lungs using 2-photon Microscopy08:50

Direct Observation of Phagocytosis and NET-formation by Neutrophils in Infected Lungs using 2-photon Microscopy

Published on: June 2, 2011

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...